Comparative effectiveness of allergy testing method in driving immunotherapy outcomes

Area of Science:

• Allergy diagnostics
• Immunotherapy
• Clinical outcomes research

Background:

• Skin-prick testing (SPT), in vitro testing (IVT), and intradermal-dilutional testing (IDT) are key methods for allergen sensitivity detection and immunotherapy dosing.
• Comparing these testing modalities is crucial for optimizing patient care and treatment protocols.

Purpose of the Study:

• To compare the effectiveness of SPT, IVT, and IDT in allergy diagnosis and immunotherapy.
• To evaluate objective and subjective measures of patient improvement based on the initial allergy testing method used.

Main Methods:

• Patients were assigned to one of three testing protocols: SPT, IVT, or a combination of screening SPT followed by IDT.
• Cost analysis was performed using institution billing data.
• Time to maintenance (TTM) therapy was analyzed, and patient symptoms were quantified using the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ).

Main Results:

• Intradermal-dilutional testing (IDT) showed a shorter median time to maintenance (TTM) therapy compared to in vitro testing (IVT) overall and in high reactors.
• No significant difference in TTM was found between IDT and skin-prick testing (SPT) in high reactors.
• No significant correlation was observed between TTM and improvements in patient-reported symptoms (RQLQ scores) across the different testing groups.

Conclusions:

• IDT facilitated quicker achievement of maintenance immunotherapy compared to IVT, but not compared to SPT.
• The choice of initial allergy testing method did not significantly influence symptom improvement as measured by RQLQ.
• This study offers a novel comparison of clinical outcomes based on the initial allergy testing modality.